Clinical trial / 1982
Nicotinamide inhibited the metabolism of primidone and increased carbamazepine levels in humans.
The effect of nicotinamide on the conversion of primidone to phenobarbital was examined in mice and three epileptic patients. In mice, 200 mg/kg of nicotinamide increased primidone's half-life by 47.6% and decreased conversion to phenobarbital and phenylethylmalonamide by 32.4% and 14.5%, respectively. In patients, nicotinamide decreased the conversion of primidone to phenobarbital, with dose correlating directly with the primidone-phenobarbital ratio (r = 0.861, p < 0.01). Nicotinamide also increased carbamazepine levels in two patients.
- Study type
- Intervention study / case series and animal study
- Who was studied
- 3 epileptic patients (and 2 treated with carbamazepine), plus mice
- What was measured
- Primidone conversion to phenobarbital, carbamazepine levels
THE PAPER
Interactions between primidone, carbamazepine, and nicotinamide.
Bourgeois BF, Dodson WE, Ferrendelli JA. Neurology, 1982.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.